Cargando…

Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States

BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, James G., Bendavid, Eran, Dietz, Patricia M., Hutchinson, Angela, Horvath, Hacsi, McCabe, Devon, Wolitski, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475783/
https://www.ncbi.nlm.nih.gov/pubmed/32885701
http://dx.doi.org/10.1177/2325958220950902
_version_ 1783579583698698240
author Kahn, James G.
Bendavid, Eran
Dietz, Patricia M.
Hutchinson, Angela
Horvath, Hacsi
McCabe, Devon
Wolitski, Richard J.
author_facet Kahn, James G.
Bendavid, Eran
Dietz, Patricia M.
Hutchinson, Angela
Horvath, Hacsi
McCabe, Devon
Wolitski, Richard J.
author_sort Kahn, James G.
collection PubMed
description BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled testing for general population (once lifetime) and high-risk populations (annual): men who have sex with men, people who inject drugs, and high-risk heterosexuals. We used published data on HIV infections, HIV testing, engagement in clinical care, and risk status disclosure. RESULTS: In clinical settings, about 76 million never-tested low-risk and 2.6 million high-risk individuals would be tested, yielding 36,000 and 55,000 HIV diagnoses, respectively. In community settings, 30 million low-risk and 4.4 million high-risk individuals would be tested, yielding 75,000 HIV diagnoses. CONCLUSION: HIV testing in clinical and community settings diagnoses similar numbers of individuals. Lifetime and risk-based testing are both needed to substantially reduce undiagnosed HIV.
format Online
Article
Text
id pubmed-7475783
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74757832020-09-17 Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States Kahn, James G. Bendavid, Eran Dietz, Patricia M. Hutchinson, Angela Horvath, Hacsi McCabe, Devon Wolitski, Richard J. J Int Assoc Provid AIDS Care Original Manuscript BACKGROUND: An estimated 166,155 individuals in the United States have undiagnosed HIV infection. We modeled the numbers of HIV-infected individuals who could be diagnosed in clinical and community settings by broadly implementing HIV screening guidelines. SETTING: United States. METHODS: We modeled testing for general population (once lifetime) and high-risk populations (annual): men who have sex with men, people who inject drugs, and high-risk heterosexuals. We used published data on HIV infections, HIV testing, engagement in clinical care, and risk status disclosure. RESULTS: In clinical settings, about 76 million never-tested low-risk and 2.6 million high-risk individuals would be tested, yielding 36,000 and 55,000 HIV diagnoses, respectively. In community settings, 30 million low-risk and 4.4 million high-risk individuals would be tested, yielding 75,000 HIV diagnoses. CONCLUSION: HIV testing in clinical and community settings diagnoses similar numbers of individuals. Lifetime and risk-based testing are both needed to substantially reduce undiagnosed HIV. SAGE Publications 2020-09-04 /pmc/articles/PMC7475783/ /pubmed/32885701 http://dx.doi.org/10.1177/2325958220950902 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Manuscript
Kahn, James G.
Bendavid, Eran
Dietz, Patricia M.
Hutchinson, Angela
Horvath, Hacsi
McCabe, Devon
Wolitski, Richard J.
Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title_full Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title_fullStr Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title_full_unstemmed Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title_short Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States
title_sort potential contributions of clinical and community testing in identifying persons with undiagnosed hiv infection in the united states
topic Original Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475783/
https://www.ncbi.nlm.nih.gov/pubmed/32885701
http://dx.doi.org/10.1177/2325958220950902
work_keys_str_mv AT kahnjamesg potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT bendavideran potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT dietzpatriciam potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT hutchinsonangela potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT horvathhacsi potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT mccabedevon potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates
AT wolitskirichardj potentialcontributionsofclinicalandcommunitytestinginidentifyingpersonswithundiagnosedhivinfectionintheunitedstates